The cytotoxicities of the antidepressants amitriptyline, imipramine (both tricyclic), fluoxetine (a selective serotonin re-uptake inhibitor) and tranylcypromine (a monoamine oxidase inhibitor) were compared in vitro in rat (C6) glioma and human (1321N1) astrocytoma cell lines. Differences in toxicity were determined after acute (24-hour) and chronic (7-day) administration and assessed by using the neutral red uptake (NRU) assay, the MTT assay, increased expression of glial fibrillary acidic protein (GFAp), and reactive morphology criteria. The relative toxicities (EC50 [concentration causing an effect in 50% of cells] value range) were fluoxetine > amitriptyline > imipramine > tranylcypromine for all the tests employed, in both cell lines and at both exposure times. There was a high and significant positive correlation between the different cell types, at both exposure times, with both the NRU and MTT assays. Increases in MTT reduction, NRU, and GFAp expression associated with cell activation were noted in C6 cells after exposure for 24 hours, but decreased after exposure for 7 days. For 1321N1 cells, increases in NRU were only observed after exposure for 24 hours. Reactive-type changes in morphology were seen after exposure to all the antidepressants, in both the C6 and 1321N1 cell lines. The data show that low concentrations of antidepressants induce metabolic changes in the astrocyte cell lines, with some significant differences in the patterns of toxicity of the tested substances.
HudsonC.J., YoungL.T., LiP.P., & WarshJ.J. (1993). CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia.Synapse13, 278–293.
2.
SommiR.W., CrismonM.L., & BowdenC.L. (1987). Fluoxetine: a serotonin-specific second generation antidepressant.Pharmacotherapy7, 1–15.
3.
BeasleyC.M., MasicaD.N., & PotvinJ.H. (1992). Fluoxetine: a review of receptor and functional effects and their clinical implications.Psychopharmacology107, 1–10.
4.
RasenickM.M., ChaneyK.A., & ChenJ. (1996). G protein-mediated signal transduction as a target of antidepressant and antibipolar drug action: evidence from model systems.Journal of Clinical Psychiatry57, Suppl. 13, 49–55.
HertzL., & RichardsonJ.S. (1983). Acute and chronic effects of antidepressant drugs on β-adrenergic function in astrocytes in primary cultures: an indication of glial involvement in affective disorders?Journal of Neuroscience Research9, 173–182.
7.
ChenY., PengL., ZhangX., StolzenburgJ. U., & HertzL. (1995). Further evidence that fluoxetine interacts with a 5-HT2C receptor in glial cells.Brain Research Bulletin38, 153–159.
8.
ChenJ., & RasenickM.M. (1995). Chronic treatment of C6 glioma cells with antidepressant drugs increases functional coupling between a G protein (Gs) and adenylyl cyclase.Journal of Neurochemistry64, 724–732.
9.
GrundtI.K., NylandH., & MørkS. (1993). Protein kinase C and phagocytic activity in amitripty-line-exposed primary cultures of glial cells.ATLA21, 181–186.
10.
PowerB.M. (1995). Antidepressant toxicity and the need for identification and concentration monitoring in overdose.Clinical Pharmacokinetics29, 154–171.
11.
FrazerA. (1997). Pharmacology of antidepressants.Journal of Clinical Psychopharmacology17, Suppl. 1, 2–18.
12.
BaldessariniR.J. (1996). Drugs and the treatment of psychiatric disorders: depression and mania. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th edn (ed. HardmanJ.G., LimbirdL.E., MolinoffP.B., RuddonR.W., & GilmanA.G.), pp. 431–461. London: McGraw-Hill.
13.
WeissM.T., & SawyerT.W. (1993). Cytotoxicity of the MEIC test chemicals in primary neurone cultures.Toxicology in Vitro7, 653–667.
14.
BondessonI., EkwallB., HellbergS., RomertL., StenbergK., & WalumE. (1989). MEIC: a new international multicentre project to evaluate the relevance to human toxicity of in vitro cytotoxicity tests.Cell Biology and Toxicology5, 331–347.
15.
ŠpanováA., KováruH., LisáV., LukášováE., & RittichB. (1997). Estimation of apoptosis in C6 glioma cells treated with antidepressants.Physiological Research46, 161–164.
16.
O'CallaghanJ.P. (1991). Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA.Neurotoxicology and Teratology13, 275–281.
17.
CooksonM.R., & PentreathV.W. (1994). Alterations in the glial fibrillary acidic protein content of primary astrocyte cultures for evaluation of glial cell toxicity.Toxicology in Vitro8, 351–359.
18.
CooksonM.R., McCleanR., WilliamsS.P., Davenport-JonesJ., EganC., O'HareS., AtterwillC.K., & PentreathV.W. (1994). Use of astrocytes for in vitro neurotoxicity testing.Toxicology in Vitro8, 817–819.
19.
SlamonN.D., & PentreathV.W. (1996). Gliotoxic effects of astrocytes in vitro.Human and Experimental Toxicology15, 662.
20.
CooksonM.R., MeadC., AustwickS.M., & PentreathV.W. (1995). Use of the MTT assay for estimating toxicity in primary astrocyte and C6 glioma cell cultures.Toxicology in Vitro9, 39–48.
21.
ZieglerV.E., CoB.T., TaylorJ.R., ClaytonP.J., & BiggsJ.J. (1976). Amitriptyline plasma levels and therapeutic response.Clinical Pharmacology and Therapeutics19, 795–802.
22.
PonsodaX., JoverR., CastellJ.V., & Gómez-LechónM.J. (1990). In vitro toxicity to two cellular systems of the first ten chemicals on the MEIC list.ATLA17, 218–223.
23.
HusøyT., SyversenT., & JenssenJ. (1993). Comparison of four in vitro cytotoxicity tests: the MTT assay, NR assay, uridine incorporation and protein measurements.Toxicology in Vitro7, 149–154.
24.
GengJ., & StrobelH.W. (1995). Identification of inducible mixed function oxidase system in rat glioma C6 cell line.Journal of Neurochemistry65, 554–563.
25.
KempermannG., KnothR., Gebicke-HaerterP.J., StolzB.J., & VolkB. (1994). Cytochrome P450 in rat astrocytes in vivo and in vitro: intracellular localization and induction by phenytoin.Journal of Neuroscience Research439, 576–588.
26.
PeuchenS., Bolan¯osJ.P., HealesS.J.R., AlmeidaA., DuchenM.R., & ClarkJ.B. (1997). Interrelationships between astrocyte function, oxidative stress and antioxidant status within the central nervous system.Progress in Neurobiology52, 261–281.
27.
LauxG., VolzH.P., & MöllerH.J. (1995). Newer and older monoamine oxidase inhibitors: a comparative profile.CNS Drugs3, 145–158.
28.
JoverR., PonsodaX., CastellJ.V., & Gómez-LechónM.J. (1992). Evaluation of the cytotoxicity of ten chemicals on human cultured hepatocytes: predictability of human toxicity and comparison with rodent cell culture systems.Toxicology in Vitro6, 47–52.
29.
EddlestonM., & MuckeL. (1993). Molecular profile of reactive astrocytes: implications for their role in neurologic disease.Neuroscience54. 15–36.
30.
O'CallaghanJ.P. (1993). Quantitative features of reactive gliosis following toxicant-induced damage of the CNS.Annals of the New York Academy of Sciences679, 195–210.
31.
McMillianM.K., ThaiL., HongJ-S., O'CallaghanJ.P., & PennypackerK.R. (1994). Brain injury in a dish: a model for reactive gliosis.Trends in Neurosciences17, 138–142.
32.
MeadC., & PentreathV.W. (1998). Hypertrophy and increased glial fibrillary acidic protein are coupled to increased protection against cytotoxicity in glioma cell lines.Toxicology in Vitro12, 141–152.
33.
SaraiK., FrazerA., BrunswickD., & MendelsJ. (1978). Desmethylimipramine-induced decrease in β-adrenergic receptor binding in rat cerebral cortex.Biochemical Pharmacology27, 2179–2181.
34.
ZhangX., PengL., ChenY., & HertzL. (1993). Stimulation of glycogenosis in astrocytes by fluoxetine, an antidepressant acting like 5-HT.Neuroreport4, 1234–1238.
35.
GrundtI.K., & NylandH. (1994). Activation of cultured glial cells by amitriptyline and platelet activating factor.Toxicology in Vitro8, 1015–1020.
36.
GrundtI.K., & RiseM. (1991). Repeated exposure of glial cells in primary cultures to amitriptyline and diazepam.ATLA19, 191–193.
